Repulsive guidance molecule a blockade exerts the immunoregulatory function in DCs stimulated with ABP and LPS

about

Repulsive guidance molecule a blockade exerts the immunoregulatory function in DCs stimulated with ABP and LPS

Item

http://www.wikidata.org/entity/Q41369735

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Repulsive guidance molecule a ...... Cs stimulated with ABP and LPS

@en

type

Item

label

Repulsive guidance molecule a ...... Cs stimulated with ABP and LPS

@en

prefLabel

Repulsive guidance molecule a ...... Cs stimulated with ABP and LPS

@en

P1476

Repulsive guidance molecule a ...... Cs stimulated with ABP and LPS

@en

P2093

Fengping Shan

http://www.w3.org/2001/XMLSchema#string

Juan Feng

http://www.w3.org/2001/XMLSchema#string

Shuo Zhang

http://www.w3.org/2001/XMLSchema#string

Xuxu Xu

http://www.w3.org/2001/XMLSchema#string

Yan Gao

http://www.w3.org/2001/XMLSchema#string

Zhiyong Zhai

http://www.w3.org/2001/XMLSchema#string

P2860

Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4

Molecular and cellular regulation of toll-like receptor-4 activity induced by lipopolysaccharide ligands

Molecular biology, genetics and biochemistry of the repulsive guidance molecule family

Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4

Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor

Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes

The repulsive guidance molecule, RGMa, promotes retinal ganglion cell survival in vitro and in vivo

CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells

Activated microglia inhibit axonal growth through RGMa

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

P304

2169-2180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2016.1164361

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26986456

http://www.w3.org/2001/XMLSchema#string

P932

4994741

http://www.w3.org/2001/XMLSchema#string